Ken completed his undergraduate degree at the University of Michigan in chemistry and biochemistry, MD-PhD training at the University of Washington, and internal medicine residency at Stanford University. His dissertation work under Professor Matt Kaeberlein involved the design of novel microfluidic devices and their application in elucidating the mechanisms linking aging and DNA damage. His research interests include the interplay between the basic biology of aging and the development, early detection, and prevention of malignancy.